Treatment-Resistant Mood DisordersJay D. Amsterdam, Mady Hornig, Andrew A. Nierenberg Cambridge University Press, 28.06.2001 - 535 Seiten Although antidepressants have helped millions worldwide, a substantial proportion of patients fail to respond or remit. There is little published information available to clinicians for diagnosis and management of treatment-resistant depression, causing them to make difficult decisions regarding treatment options with very limited data. The editors and their internationally distinguished team of contributors have set out to address this problem, giving a critical assessment of all aspects of treatment-resistant depression: causes, epidemiology, comorbidity, evaluation, and treatment. This timely book will be invaluable to clinicians, neuroscientists, researchers, and graduate students. |
Inhalt
IV | 3 |
V | 30 |
VI | 47 |
VII | 49 |
VIII | 80 |
IX | 96 |
X | 111 |
XI | 142 |
XVIII | 252 |
XIX | 271 |
XX | 273 |
XXI | 288 |
XXII | 321 |
XXIII | 350 |
XXIV | 405 |
XXV | 430 |
Andere Ausgaben - Alle anzeigen
Treatment-Resistant Mood Disorders Jay D. Amsterdam,Mady Hornig,Andrew A. Nierenberg Eingeschränkte Leseprobe - 2001 |
Treatment-Resistant Mood Disorders Jay D. Amsterdam,Mady Hornig,Andrew A. Nierenberg Keine Leseprobe verfügbar - 2007 |
Häufige Begriffe und Wortgruppen
acute adequate adolescents Affective Disorders agents alcohol American Journal American Psychiatric Amsterdam antidepressant treatment Archives associated behavior Biological Psychiatry bipolar disorder brain British Journal carbamazepine chronic Clinical Psychiatry Clinical Psychopharmacology clinician cognitive combination comorbidity controlled cortisol decreased depressed patients depressive symptoms desipramine diagnosis disease dose double-blind drug dysthymia efficacy elderly estrogen fluoxetine imipramine increased inpatients Joffe Journal of Affective Journal of Clinical Journal of Psychiatry lamotrigine levels lithium augmentation major depressive disorder mania manic MAOI medication Medicine metabolism mg/day monoamine oxidase inhibitors mood disorders mood stabilizers neuroleptics non-response outcome personality disorders pharmacological pharmacotherapy phenelzine placebo placebo-controlled plasma potential pregnancy Psychopharmacology psychotherapy receptor refractory depression reported resistant depression reuptake inhibitors risk serotonin sertraline serum side effects significant sleep SSRI strategies suggest suicide syndrome Thase therapeutic thyroid hormone treated treatment of depression treatment-resistant depression trial tricyclic antidepressants unipolar depression valproate venlafaxine weeks women